⚠️ Serious warning: Nothing on this website is approved by any physician. Doz is only a tool to help physicians and to search drugs easily. Taking medicines without medical supervision can be fatal.

Lisinopril

لیزینوپریل

⚠ Unverified

❤️ Cardiovascular SystemACE inhibitor

🤰 Pregnancy:Dangerous / avoid 🤱 Breastfeeding:Dangerous / avoid 👶 Children:Use with caution 👴 Older adults:No specific problem stated 🇮🇷 Registered in Iran ⛔ 3 contraindications 🇺🇸 FDA approved generic (ANDA) ANDA077321 ATC C09AA03

Market / country: 🇺🇸 USA

Zestril (US) · Prinivil (US)

🧮 Dose calculator

Disease / regimen

Hypertension · Regimen source: FDA Lisinopril · 2.1

• Usual 20–40 mg/day once. On diuretics: start 5 mg. CrCl 10–30: halve; <10 or dialysis: 2.5 mg. FDA Lisinopril · 2.1 FDA Lisinopril · 2 FDA Lisinopril · 2.4

Formulation

Age *

Weight (kg) (optional)

Enter age (weight is optional for this regimen).

🛡️ Safety & information

Contraindications

⛔ History of angioedema; hypersensitivity; aliskiren in diabetes; with sacubitril (36 h gap). FDA Lisinopril · 4
⛔ Not recommended under 6 years. FDA Lisinopril · 2.1
⚠️ Boxed warning: fetal toxicity — stop as soon as pregnancy is detected. FDA Lisinopril · Boxed Warning

Formulations

2.5 mg tablet — tablet 🇺🇸 USA FDA Lisinopril · 3
5 mg tablet — tablet 🇺🇸 USA FDA Lisinopril · 3
10 mg tablet — tablet 🇺🇸 USA FDA Lisinopril · 3
20 mg tablet — tablet 🇺🇸 USA FDA Lisinopril · 3
30 mg tablet — tablet 🇺🇸 USA FDA Lisinopril · 3
40 mg tablet — tablet 🇺🇸 USA FDA Lisinopril · 3

👥 Special populations

🤰 PregnancyDangerous / avoid
Label: can cause fetal harm. Dangerous in pregnancy. FDA Lisinopril · Boxed Warning
“WARNING: FETAL TOXICITY See full prescribing information for complete boxed warning.”
🤱 BreastfeedingDangerous / avoid
Label: breastfeeding not recommended, or choose between the drug and breastfeeding. FDA Lisinopril · 8.2
“Because of the potential for severe adverse reactions in the breastfed infant, advise women not to breastfeed during treatment with lisinopril.”
👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Lisinopril · 8.4
“Antihypertensive effects and safety of lisinopril have been established in pediatric patients aged 6 to 16 years [see DOSAGE AND ADMINISTRATION ( 2.1 ) and CLINICAL STUDIES ( 14.1 )] .”
👴 Older adultsNo specific problem stated
Label: no specific difference or dose adjustment stated for older adults. FDA Lisinopril · 8.5
“No dosage adjustment with lisinopril is necessary in elderly patients.”
⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.

🔗 Reference links

FDA (approval record)ANDA077321
DailyMed (FDA label)FDA Lisinopril
MedlinePlus (NIH)Lisinopril
WHO ATC/DDDC09AA03
Darooyab (Iran)Lisinopril

🇮🇷 Registered in Iran Darooyab · G-1741/Lisinopril

Dosage forms with Iranian generic codes, per Darooyab.

00764 · LISINOPRIL 10MG TAB · قرص لیزینوپریل ۱۰ میلی‌گرم
00765 · LISINOPRIL 20MG TAB · قرص لیزینوپریل ۲۰ میلی‌گرم
00766 · LISINOPRIL 5MG TAB · قرص لیزینوپریل ۵ میلی‌گرم

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

FDA label (DailyMed)✅ Present
FDA Lisinopril · 3 FDA Lisinopril · 2.1 FDA Lisinopril · 2 FDA Lisinopril · 2.4 FDA Lisinopril · 2.2 FDA Lisinopril · 2.3 FDA Lisinopril · 4 FDA Lisinopril · Boxed Warning FDA Lisinopril · 8.2 FDA Lisinopril · 8.4 FDA Lisinopril · 8.5 FDA Lisinopril · SPL approval / marketing category
UK SmPC (eMC / MHRA)❌ Not present
Published guideline❌ Not present
Licensed reference (medical school)❌ Not present
Iranian leaflet (IFDA)❌ Not present
Pharmacy website (secondary, unreliable)✅ Present
Darooyab · G-1741/Lisinopril
Clinical review⚠ Unverified